PDCD1 and cancer: In cancer patients, T cell exhaustion may result in failure to eliminate tumors, which can be therapeutically reversed by reinvigorating exhausted-like T cells (Tex) cells using inhibitory receptor blockade (e.g., anti-PD-1)2,4.